Relapse rates after detox and rehabilitation remain a significant challenge in the treatment of substance use disorder (SUD). Studies show that between 40% and...
In a surprising and strategic move, FOXO Technologies (NYSE American: FOXO), a biotech company known for its advancements in epigenetics and AI-driven health solutions,...
A bipartisan group of five U.S. senators recently announced a significant legislative effort aimed at improving addiction treatment in prisons. The bill, called the...